{"entity":{"type":"insider","cik":"0001743780","url":"/insider/0001743780","json_url":"/insider/0001743780.json","name":"Takimoto Chris H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":19,"first":"2019-01-08","last":"2024-09-17","span_basis":"filed_date"},"name_variants":[{"name":"Takimoto Chris H","source":"filing","n_filings":19,"first_seen":"2019-01-08","last_seen":"2024-09-17"}],"transactions":[{"id":3237594,"accession":"0001415889-24-023588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023588","line_url":"/filing/0001415889-24-023588#line-1","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1487.0,"shares_display":"1,487","price_per_share":11.5388,"price_display":"11.54","price_state":"stated","total_value":17158.1956,"total_display":"17,158.20","total_whole":"17,158","shares_owned_after":154331.0,"shares_owned_after_display":"154,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-17","scope":"insider"},{"id":2070028,"accession":"0001415889-24-017500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-017500","line_url":"/filing/0001415889-24-017500#line-2","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1570.0,"shares_display":"1,570","price_per_share":7.5753,"price_display":"7.58","price_state":"stated","total_value":11893.221,"total_display":"11,893.22","total_whole":"11,893","shares_owned_after":95818.0,"shares_owned_after_display":"95,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2024-06-18","scope":"insider"},{"id":2329284,"accession":"0001415889-24-008171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-008171","line_url":"/filing/0001415889-24-008171#line-2","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2535.0,"shares_display":"2,535","price_per_share":10.1705,"price_display":"10.17","price_state":"stated","total_value":25782.2175,"total_display":"25,782.22","total_whole":"25,782","shares_owned_after":94388.0,"shares_owned_after_display":"94,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2329280,"accession":"0001415889-24-008171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-008171","line_url":"/filing/0001415889-24-008171#line-1","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2889.0,"shares_display":"2,889","price_per_share":9.8752,"price_display":"9.88","price_state":"stated","total_value":28529.4528,"total_display":"28,529.45","total_whole":"28,529","shares_owned_after":96923.0,"shares_owned_after_display":"96,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-15","scope":"insider"},{"id":8727473,"accession":"0001209191-23-057113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057113","line_url":"/filing/0001209191-23-057113#line-1","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1180.0,"shares_display":"1,180","price_per_share":6.213,"price_display":"6.21","price_state":"stated","total_value":7331.34,"total_display":"7,331.34","total_whole":"7,331","shares_owned_after":53562.0,"shares_owned_after_display":"53,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-01","scope":"insider"},{"id":8112440,"accession":"0001209191-23-032306","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-032306","line_url":"/filing/0001209191-23-032306","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1259.0,"shares_display":"1,259","price_per_share":12.308893566322478,"price_display":"12.31","price_state":"stated","total_value":15496.897,"total_display":"15,496.90","total_whole":"15,497","shares_owned_after":54757.0,"shares_owned_after_display":"54,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-25","scope":"insider","n_lines":2},{"id":8215477,"accession":"0001209191-23-019421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-019421","line_url":"/filing/0001209191-23-019421#line-1","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1768.0,"shares_display":"1,768","price_per_share":18.732,"price_display":"18.73","price_state":"stated","total_value":33118.176,"total_display":"33,118.18","total_whole":"33,118","shares_owned_after":28789.0,"shares_owned_after_display":"28,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-16","scope":"insider"},{"id":6677246,"accession":"0001209191-22-062262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-062262","line_url":"/filing/0001209191-22-062262","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5430.0,"shares_display":"5,430","price_per_share":18.983354364640885,"price_display":"18.98","price_state":"stated","total_value":103079.6142,"total_display":"103,079.61","total_whole":"103,080","shares_owned_after":32495.0,"shares_owned_after_display":"32,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-20","scope":"insider","n_lines":2},{"id":6432282,"accession":"0001209191-22-058913","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-058913","line_url":"/filing/0001209191-22-058913","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":877.0,"shares_display":"877","price_per_share":21.570715849486888,"price_display":"21.57","price_state":"stated","total_value":18917.5178,"total_display":"18,917.52","total_whole":"18,918","shares_owned_after":36264.0,"shares_owned_after_display":"36,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-28","scope":"insider","n_lines":2},{"id":6630584,"accession":"0001209191-22-032233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-032233","line_url":"/filing/0001209191-22-032233#line-1","is_derivative":false,"issuer_cik":"0001496323","issuer_name":"IGM Biosciences, Inc.","issuer_ticker":"IGMS","issuer_name_source":null,"issuer_url":"/issuer/0001496323","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":938.0,"shares_display":"938","price_per_share":17.1039,"price_display":"17.10","price_state":"stated","total_value":16043.4582,"total_display":"16,043.46","total_whole":"16,043","shares_owned_after":36864.0,"shares_owned_after_display":"36,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-26","scope":"insider"},{"id":2109979,"accession":"0001209191-20-023395","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-023395","line_url":"/filing/0001209191-20-023395#line-6","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79195.0,"shares_display":"79,195","price_per_share":95.42,"price_display":"95.42","price_state":"stated","total_value":7556786.9,"total_display":"7,556,786.90","total_whole":"7,556,787","shares_owned_after":3906.0,"shares_owned_after_display":"3,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-01","filed_date":"2020-04-03","scope":"insider"},{"id":7981152,"accession":"0001209191-19-060143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060143","line_url":"/filing/0001209191-19-060143#line-2","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":8210638,"accession":"0001209191-19-059961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-059961","line_url":"/filing/0001209191-19-059961#line-2","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider"},{"id":8010102,"accession":"0001209191-19-046934","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046934","line_url":"/filing/0001209191-19-046934#line-1","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":663.0,"shares_display":"663","price_per_share":6.3586,"price_display":"6.36","price_state":"stated","total_value":4215.7518,"total_display":"4,215.75","total_whole":"4,216","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-21","scope":"insider"},{"id":8005387,"accession":"0001209191-19-028110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-028110","line_url":"/filing/0001209191-19-028110#line-2","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":17.9939,"price_display":"17.99","price_state":"stated","total_value":143951.2,"total_display":"143,951.20","total_whole":"143,951","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-03","filed_date":"2019-05-07","scope":"insider"},{"id":7922316,"accession":"0001209191-19-024045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-024045","line_url":"/filing/0001209191-19-024045#line-2","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":16.3881,"price_display":"16.39","price_state":"stated","total_value":131104.8,"total_display":"131,104.80","total_whole":"131,105","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-04","filed_date":"2019-04-08","scope":"insider"},{"id":8724642,"accession":"0001209191-19-017588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-017588","line_url":"/filing/0001209191-19-017588#line-2","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":16.9438,"price_display":"16.94","price_state":"stated","total_value":135550.4,"total_display":"135,550.40","total_whole":"135,550","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-06","scope":"insider"},{"id":8674475,"accession":"0001209191-19-012322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-012322","line_url":"/filing/0001209191-19-012322#line-1","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.0485,"price_display":"15.05","price_state":"stated","total_value":37621.25,"total_display":"37,621.25","total_whole":"37,621","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-21","scope":"insider"},{"id":7787549,"accession":"0001209191-19-007526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-007526","line_url":"/filing/0001209191-19-007526#line-2","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":14.8592,"price_display":"14.86","price_state":"stated","total_value":118873.6,"total_display":"118,873.60","total_whole":"118,874","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-04","filed_date":"2019-02-05","scope":"insider"},{"id":8062958,"accession":"0001209191-19-002922","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-002922","line_url":"/filing/0001209191-19-002922#line-2","is_derivative":false,"issuer_cik":"0001667633","issuer_name":"Forty Seven, Inc.","issuer_ticker":"FTSV","issuer_name_source":null,"issuer_url":"/issuer/0001667633","owner_cik":"0001743780","owner_name":"Takimoto Chris H","owner_display_name":"Takimoto Chris H","owner_url":"/insider/0001743780","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":15.5453,"price_display":"15.55","price_state":"stated","total_value":124362.4,"total_display":"124,362.40","total_whole":"124,362","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-04","filed_date":"2019-01-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001496323","name":"IGM Biosciences, Inc.","url":"/issuer/0001496323","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":9,"first_seen":"2022-05-26","last_seen":"2024-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001667633","name":"Forty Seven, Inc.","url":"/issuer/0001667633","role":"Officer (Chief Medical Officer)","n_filings":10,"first_seen":"2019-01-08","last_seen":"2020-04-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001743780","retrieved_at":"2026-08-23T11:10:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}